Fig. 6
From: The chromatin remodeling subunit Baf200 promotes normal hematopoiesis and inhibits leukemogenesis
Baf200-deficient BM HSCs have a significantly impaired long-term reconstitution capacity. a Scheme of competitive BM transplantation assay for WT and Vav-iCre+, Baf200f/f mice. b The graph showing the relative ratios of CD45.2 versus CD45.1 of the indicated cell types in recipient mice 16 weeks after transplantation (n = 7 per genotype for each subset). c Scheme of competitive BM transplantation assay for WT and Mx1-Cre+, Baf200f/f mice. d Percentage of donor-derived T cells (left), B cells (middle), and neutrophils (right) in the peripheral blood from recipient mice assessed at different time point (n = 5 per genotype for each subset). Data are shown as means ± SEM. ***P < 0.001